Epinephrine Injection Recalled Due to Sterility Assurance Failure
Central Admixture Pharmacy Services is recalling epinephrine injection (4 mg/250 mL) following FDA inspection findings that the product's sterility cannot be assured.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is a sterile injectable medication where FDA inspection raised concerns about sterility assurance. While no illnesses or injuries have been reported, lack of sterility assurance for injectable products poses significant risk of infection if contaminated, meeting the criterion of risk-of-harm products where injury has not yet been reported.
Plain-English summary
Central Admixture Pharmacy Services, Inc. is recalling 5,627 bags of epinephrine added to dextrose 5% (4 mg/250 mL) with NDC 71285-7018-1. The product is a sterile injectable medication distributed nationwide in the USA.
The recall was initiated following an FDA inspection that raised questions about whether the sterility of the product could be assured. Sterile injectable medications must maintain strict sterility standards to ensure safety.
Healthcare facilities and providers that have received affected lots should discontinue use immediately. The affected lot numbers and expiration dates are: 37-883218 (04/30/2023), 37-885235 (05/08/2023), 37-885923 (05/10/2023), 37-889050 (05/23/2023), 37-890053 and 37-890054 (05/28/2023), 37-891439 and 37-891441 (06/01/2023), 37-892500 (06/06/2023), 37-894308 (06/13/2023), 37-896125 (06/20/2023), 37-896926 (06/22/2023), and 37-900396 (07/06/2023).
The recalled product
- Product
- EPINEPHrine added to dextrose 5%, 4 mg/250 mL* (16 mcg/mL), 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-7018-1.
- Manufacturer
- Central Admixture Pharmacy Services, Inc.
- Category
- Drug — Sterile Injectable
- Affected units
- 5,627
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot # 37-883218
- Exp 04/30/2023
- 37-885235
- Exp 05/08/2023
- 37-885923
- Exp 05/10/2023
- 37-889050
- Exp 05/23/2023
- 37-890053
- 37-890054
- Exp 05/28/2023
- 37-891439
- 37-891441
- Exp 06/01/2023
- 37-892500
- Exp 06/06/2023
- 37-894308
- Exp 06/13/2023
- 37-896125
- Exp 06/20/2023
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 108 recalled by Central Admixture Pharmacy Services, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 108 products in this recall →Related recalls
Same manufacturer · Central Admixture Pharmacy Services, Inc.
See all →- ModeratePediatric TPN Bags Recalled for Incorrect Formulation
FDA (Drugs) · 2026-08-12
- SeverePediatric Total Parenteral Nutrition Bag Recalled for Incorrect Formulation
FDA (Drugs) · 2026-07-01
- SevereInjectable Phenylephrine Solution Recalled Due to Particulate Matter Contamination
FDA (Drugs) · 2025-03-19
- HighInjectable Lidocaine Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2023-10-11
- HighMidazolam Injectable Solution Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2023-10-11
Same hazard · sterility assurance failure
See all →- HighDELFLEX Peritoneal Dialysis Solution bags recalled for sterility risk
FDA (Drugs) · 2026-05-13
- SevereTirzepatide/Cyanocobalamin Injectable Recalled Due to Sterility Assurance Failure
FDA (Drugs) · 2025-07-02
- HighOmnicell IVX Station Reconstitution Transfer Sets Recall
FDA (Devices) · 2025-04-16
- HighCompounded Fentanyl and Bupivacaine Epidural Injections Recalled for Sterility Assurance
FDA (Drugs) · 2025-04-02
- HighHYDROmorphone Injectable Recalled Due to Sterility Assurance Failure
FDA (Drugs) · 2024-04-03